Genetron Holdings Ltd - ADR logo

GTH

Genetron Holdings Ltd - ADR

$1.23

Earnings Summary

Revenue
$110.32Mn
Net Profits
$-174.37Mn
Net Profit Margins
-158.06%

Highlights

Revenue:

Genetron Holdings Ltd - ADR’s revenue jumped 19.83% since last year same period to $110.32Mn in the Q1 2022. On a quarterly growth basis, Genetron Holdings Ltd - ADR has generated -24.88% fall in its revenue since last 3-months.

Net Profits:

Genetron Holdings Ltd - ADR’s net profit fell -51.58% since last year same period to $-174.37Mn in the Q1 2022. On a quarterly growth basis, Genetron Holdings Ltd - ADR has generated -7.18% fall in its net profits since last 3-months.

Net Profit Margins:

Genetron Holdings Ltd - ADR’s net profit margin fell -26.49% since last year same period to -158.06% in the Q1 2022. On a quarterly growth basis, Genetron Holdings Ltd - ADR has generated -42.68% fall in its net profit margins since last 3-months.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Genetron Holdings Ltd - ADR post its latest quarter earnings

EPS Estimate Current Quarter
-0.04
EPS Estimate Current Year
-0.04

Highlights

EPS Estimate Current Quarter:

Genetron Holdings Ltd - ADR’s earning per share (EPS) estimates for the current quarter stand at -0.04 - a 95.38% jump from last quarter’s estimates.

EPS Estimate Current Year:

Genetron Holdings Ltd - ADR’s earning per share (EPS) estimates for the current year stand at -0.04.

Key Ratios

Key ratios of the Genetron Holdings Ltd - ADR post its Q1 2022 earnings

Earning Per Share (EPS)
-0.3
Return on Assets (ROA)
-0.23
Return on Equity (ROE)
-0.43
Dividend Per Share (DPS)
0

Highlights

Earning Per Share (EPS):

Genetron Holdings Ltd - ADR’s earning per share (EPS) jumped 73.74% since last year same period to -0.3 in the Q1 2022. This indicates that the Genetron Holdings Ltd - ADR has generated 73.74% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Return on Assets (ROA):

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Genetron Holdings Ltd - ADR’s return on assets (ROA) stands at -0.23.

Earning Per Share (EPS):

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Genetron Holdings Ltd - ADR’s return on equity (ROE) stands at -0.43.

Dividend Per Share (DPS):

Genetron Holdings Ltd - ADR declared 0 dividend per share during the earnings announcement for Q1 2022.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2021-09-30
-0.04
-0.18
-339.76%
2021-06-30
-0.91
-0.15
83.01%
2021-03-31
-0.65
-1.13
-73.85%

Company Information

Genetron Holdings Limited ("Genetron Health" or the "Company") is a leading precision oncology platform company in China that specializes in cancer molecular profiling and harnesses advanced technologies in molecular biology and data science to transform cancer treatment. The Company has developed a comprehensive oncology portfolio that covers the entire spectrum of cancer management, addressing needs and challenges from early screening, diagnosis and treatment recommendations, as well as continuous disease monitoring and care. Genetron Health also partners with global biopharmaceutical companies and offers customized services and products.

Organisation
Genetron Holdings Ltd - ADR
Employees
2.02K
Industry
Health Services